BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:38th Pharmacovigilance USA 2025\n\n“Ensuring safer drugs to ma rket. Latest developments in PV”\n\n07th &\; 8th May 2025\, The Inn at Longwood Medical\, Boston\, Massachusetts\, USA\n\n38th Pharmacovigilanc e USA 2025 will bring together top pharmaceutical\, biotechnology and reg ulatory\, vendor representatives under one roof that will address the key issues of the industry. Get more from the event\, with a broader scope b ringing the whole communications value chain together.\n\nPlease contact me for Sponsor / Exhibit / Booth / Delegate at E-mail - kavitha@virtueins ight.co.in or Call - +44 20 3509 3779\n\nSPONSORS:\n\nGold Sponsors: Cenc ora\, Arisglobal\n\nSilver Sponsors: Veeva Systems\, HMGlobal Pharmacovig ilance Consulting\n\nWe have more sponsorship opportunities available for the event\, which gives you an opportunity to exhibit/booth/speak and cr eate brand awareness. Please email to kavitha@virtueinsight.co.in for mor e details.\n\nDELEGATE REGISTRATION:\n\nRegistration for this conference through any third party site will involve VAT or TAX. If you would like t o register without Tax please register through site\n\nhttps://virtueinsi ght.com/event/pharmacovigilance-usa-2025/\n\nSuper Early Bird Price (Vali d Till 11th March 2024)\n\n01 Delegate - $999\n\n4 Delegates for the pric e of 2 - $1998\n\nEarly Bird Price (Valid till 12th March 2024 -11th Apri l 2024)\n\n01 Delegate - $1100\n\n4 Delegates for the price of 2 - $2200\ n\nStandard Price (From 12th April 2024)\n\n01 Delegate - $1599\n\n4 Dele gates for the price of 2 - $3198\n\nKEY SPEAKERS:\n\n\nKHAUDEJA BANO\, VP - Global Head of Device Quality\, Roche - Genentech\nMARIETTE BOERSTOEL- STREEFLAND\, SVP\, Worldwide Patient Safety Officer\, Bristol-Myers Squib b\nMILIND SARDESA\, Senior Director\, Safety Surveillance\, Global Patien t Safety\, Novo Nordisk\nNINA KOLA\, VP\, Head Medical Safety Assessment Hematology and Oncology\, Bristol-Myers Squibb\nDANYTZA WARD\, Executive Director\, Head of PV Operations &\; Global Risk Management\, Jazz Pha rmaceuticals\nCARMIT STRAUSS\, Executive Director\, Head of Risk Manageme nt and Organ Toxicity\, Takeda Pharmaceuticals\n ALTON SARTOR\, Medical D irector\, Patient Safety Physician Digital &\; Devices\, AstraZeneca\n JESSICA CHINAULT-JALBOOT\, Exec Dir\, Regulatory and PV Compliance\, Jazz Pharmaceuticals\nKARTHIK MUTHUSAMI\, Head of Expedited Safety Reporting\ , Bristol-Myers Squibb\nWILLIAM A. BLUMENTALS\, Head of Pharmacoepidemiol ogy\, Specialty Care\, Sanofi\nSHARON REID\, Director of Risk Management Center of Excellence\, Pfizer\nKSHITIJA BAPAT\, Dir\, Compliance Operatio ns\, Jazz Pharmaceuticals\nVIKALP KHARE\, Director\, Otsuka Pharmaceutica l\nBEENA WOOD\, Head of Innovation &\; Technology\, CSL Behring\nREEM YASIN\, Quality Assurance &\; PV Manager\, Hawkary Pharmaceuticals (Ir aq)\nABBEY GOW\, QA &\; Deviation Management Expert\, Sanofi\nSIVA KUM AR BUDDHA\, Director - PV (Head of Signal &\; Risk Management)\, Indeg ene\nANKA EHRHARDT\, Director\, Cell-Based Assays / Analytical Research & amp\; Development\, Merck\nJASON BRYANT\, VP Data &\; AI\, ArisGlobal\ nKARTHIK BABU\, CHC Global PV Operations Head\, Sanofi\nHEATHER LEIGH FLA NNERY\, CEO &\; Co-Founder\, AI MINDSystems Foundation\nASHISH JAIN\, Sr\, Director\, Clinical Safety &\; Pharmacovigilance\, Curis\nMEERA N AGARIA\, Senior Data Scientist\, Johnson &\; Johnson\nKAPIL BHUTADA\, Head of PV Safety Operation &\; Compliance\, Asklepios BioPharmaceutic al\nHEATHER MURPHY\, Founder and CEO\, HMGlobal Pharmacovigilance Consult ing\nBEN LOCWIN\, VP\, Project Solutions\, Black Diamond Networks\n\nPlus more joining soon\n\nFOCUS AREAS:\n\n\nMarket Trends - Critique &\; W ays Forward\nChallenges / Opportunities\nPatient Safety / Patient Centric ity\nImpact of Technology - AI\, ML\, DA\nRMP / REMS\nQuality\, Safety &a mp\; Signal Detection\nAutomation in PV\nRegulatory\nAudits &\; Inspec tion\nRWE / RWD\nOutsourcing\n\nWHO SHOULD ATTEND: \; \; \;&n bsp\; \; \; \n\nCEO’s\, CTO’s\, CIO’s\, Presidents\, VPs\, Direct ors\, Heads\, Managers\, Scientific Advisors\, Consultants of:\n\nPharmac ovigilance\, Pharmacoepidemiology\, Pharmacogenomics\, Drug/Product Safet y\, Drug Development\, Information and Clinical Data Management\, Clinica l Pharmacology\, Clinical Safety\, Periodical safety update Reports\, Ris k Management\, Research &\; Development\, Quality Assurance\, Patient Safety\, Signal Detection\, Safety Surveillance\, Outcomes Research\, Dat a Analysis\, Epidemiology\, Medical Affairs\, Regulatory Affairs and Comp liance\, Information technology\, Sales and Marketing.\n\nGet more from t he event\, with a broader scope bringing the whole communications value c hain together. Enjoy and make the best out of our dedicated networking ti me\, and meet the leading international vendors showcasing the products o f tomorrow in the co-located exhibition. Expand your knowledge of the lat est business models and strategies at the high-levelconference.\n DTEND:20250508T170000 DTSTAMP:20260512T223118Z DTSTART:20250507T090000 LOCATION:The Inn At Longwood Medical\, 342\, Longwood Avenue\, Suffolk Cou nty\, 02115\, SEQUENCE:0 SUMMARY:38th Pharmacovigilance USA 2025\n“Ensuring safer drugs to market. Latest developments in PV”\n07th &\; 8th May 2025\, The Inn at Longwoo d Medical\,... UID:e84a8e68-132b-4975-be63-448610ee5c46 END:VEVENT END:VCALENDAR